US Stock MarketDetailed Quotes

Revolution Medicines (RVMD)

Watchlist
  • 135.300
  • +0.820+0.61%
Close Apr 24 16:00 ET
  • 135.300
  • 0.0000.00%
Post 20:01 ET
28.24BMarket Cap-22.74P/E (TTM)

Revolution Medicines (RVMD) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-61.05%-897.74M
-98.31%-274.24M
-58.96%-207.31M
-73.02%-221.76M
-21.10%-194.44M
-59.01%-557.44M
-14.70%-138.29M
-29.77%-130.42M
-90.95%-128.17M
-157.34%-160.56M
Net income from continuing operations
-88.52%-1.13B
-87.54%-364.89M
-95.28%-305.21M
-85.98%-247.79M
-83.97%-213.42M
-37.52%-600.09M
-20.45%-194.57M
-44.13%-156.29M
-35.54%-133.23M
-70.35%-116M
Operating gains losses
465.99%15.39M
63,035.00%12.63M
-57.58%624K
345.60%4.58M
36.35%-2.44M
-2,617.96%-4.21M
-87.95%20K
--1.47M
---1.86M
-383,300.00%-3.83M
Depreciation and amortization
40.04%16.56M
38.82%4.7M
50.78%4.34M
35.93%3.8M
34.49%3.72M
27.02%11.82M
18.51%3.39M
34.13%2.88M
57.76%2.8M
9.08%2.76M
Other non cash items
--24.23M
--11.94M
--11.43M
----
----
----
----
----
----
----
Change In working capital
21,284.98%86.82M
-23.26%32.25M
445.92%56.44M
9.22%-4.3M
105.16%2.44M
-98.90%406K
98.62%42.02M
478.72%10.34M
-122.28%-4.74M
-1,500.98%-47.21M
-Change in receivables
--0
--0
--0
--0
--0
-63.32%1.25M
--0
--0
--0
84.96%1.25M
-Change in prepaid assets
-25.64%-21.69M
-40.50%-10.67M
-1,297.78%-10.08M
11.88%-7.36M
1,189.15%6.43M
-250.12%-17.26M
-67.48%-7.6M
17.13%-721K
-635.95%-8.35M
-136.62%-590K
-Change in payables and accrued expense
684.81%121.8M
-7.47%44.1M
765.33%64.84M
84.99%19.58M
86.62%-6.72M
-67.07%15.52M
164.58%47.66M
-8.14%7.49M
-55.47%10.59M
-1,692.26%-50.22M
-Change in other current assets
-862.56%-12.87M
-106.18%-154K
18.55%3.79M
-318.54%-17.27M
512.00%765K
94.02%1.69M
-73.38%2.49M
136.86%3.2M
-4,789.77%-4.13M
38.89%125K
-Change in other current liabilities
-1,172.73%-420K
-557.33%-1.03M
-669.73%-2.11M
126.36%750K
-11.28%1.97M
97.60%-33K
132.19%225K
14.91%370K
-90.05%-2.85M
344.29%2.22M
-Change in other working capital
----
----
----
----
----
90.89%-762K
----
----
----
----
Cash from discontinued investing activities
Operating cash flow
-61.05%-897.74M
-98.31%-274.24M
-58.96%-207.31M
-73.02%-221.76M
-21.10%-194.44M
-59.01%-557.44M
-14.70%-138.29M
-29.77%-130.42M
-90.95%-128.17M
-157.34%-160.56M
Investing cash flow
Cash flow from continuing investing activities
121.29%118.06M
119.06%74.88M
215.74%24.85M
-68.25%34.28M
93.57%-15.95M
-61.82%-554.39M
-3.29%-392.9M
-127.75%-21.47M
347.90%107.94M
-6,305.36%-247.97M
Net PPE purchase and sale
-55.12%-15.99M
-57.53%-1.93M
4.86%-3.35M
-210.55%-7.45M
-3.13%-3.27M
-33.37%-10.31M
47.26%-1.22M
-38.86%-3.52M
-114.39%-2.4M
-80.15%-3.17M
Net investment purchase and sale
124.64%134.05M
119.61%76.81M
257.10%28.2M
-62.19%41.73M
94.82%-12.68M
-62.48%-544.09M
-3.60%-391.68M
-122.47%-17.95M
360.09%110.34M
-4,354.41%-244.8M
Cash from discontinued investing activities
Investing cash flow
121.29%118.06M
119.06%74.88M
215.74%24.85M
-68.25%34.28M
93.57%-15.95M
-61.82%-554.39M
-3.29%-392.9M
-127.75%-21.47M
347.90%107.94M
-6,305.36%-247.97M
Financing cash flow
Cash flow from continuing financing activities
-35.22%621.52M
-58.15%365.66M
-102.06%-1.59M
3,319.28%256.58M
7.90%874K
-21.95%959.41M
4.10%873.81M
7,545.30%77.29M
-88.39%7.5M
-99.75%810K
Net common stock issuance
-58.89%347.92M
-54.94%347.92M
----
----
----
119.40%846.35M
--772.06M
--74.29M
--0
--0
Proceeds from stock option exercised by employees
142.41%273.39M
157.99%261.77M
38.22%4.15M
-12.30%6.58M
10.12%892K
1,600.30%112.78M
3,885.31%101.47M
196.83%3M
191.19%7.5M
62.32%810K
Net other financing activities
-22.54%220K
---244.02M
---5.74M
--250M
---18K
-99.97%284K
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
-35.22%621.52M
-58.15%365.66M
-102.06%-1.59M
3,319.28%256.58M
7.90%874K
-21.95%959.41M
4.10%873.81M
7,545.30%77.29M
-88.39%7.5M
-99.75%810K
Net cash flow
Beginning cash position
-21.80%546.76M
8.89%222.3M
45.78%406.35M
15.71%337.25M
-21.80%546.76M
328.55%699.18M
-43.42%204.15M
-27.21%278.74M
-32.05%291.46M
328.55%699.18M
Current changes in cash
-3.77%-158.16M
-51.46%166.3M
-146.74%-184.05M
643.30%69.1M
48.61%-209.51M
-128.43%-152.42M
1.25%342.61M
-237.01%-74.59M
72.37%-12.72M
-253.39%-407.72M
End cash Position
-28.93%388.6M
-28.93%388.6M
8.89%222.3M
45.78%406.35M
15.71%337.25M
-21.80%546.76M
-21.80%546.76M
-43.42%204.15M
-27.21%278.74M
-32.05%291.46M
Free cash flow
-60.94%-913.73M
-97.95%-276.16M
-57.28%-210.66M
-75.55%-229.21M
-20.75%-197.7M
-58.45%-567.74M
-13.54%-139.51M
-30.00%-133.94M
-91.33%-130.57M
-155.23%-163.73M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -61.05%-897.74M-98.31%-274.24M-58.96%-207.31M-73.02%-221.76M-21.10%-194.44M-59.01%-557.44M-14.70%-138.29M-29.77%-130.42M-90.95%-128.17M-157.34%-160.56M
Net income from continuing operations -88.52%-1.13B-87.54%-364.89M-95.28%-305.21M-85.98%-247.79M-83.97%-213.42M-37.52%-600.09M-20.45%-194.57M-44.13%-156.29M-35.54%-133.23M-70.35%-116M
Operating gains losses 465.99%15.39M63,035.00%12.63M-57.58%624K345.60%4.58M36.35%-2.44M-2,617.96%-4.21M-87.95%20K--1.47M---1.86M-383,300.00%-3.83M
Depreciation and amortization 40.04%16.56M38.82%4.7M50.78%4.34M35.93%3.8M34.49%3.72M27.02%11.82M18.51%3.39M34.13%2.88M57.76%2.8M9.08%2.76M
Other non cash items --24.23M--11.94M--11.43M----------------------------
Change In working capital 21,284.98%86.82M-23.26%32.25M445.92%56.44M9.22%-4.3M105.16%2.44M-98.90%406K98.62%42.02M478.72%10.34M-122.28%-4.74M-1,500.98%-47.21M
-Change in receivables --0--0--0--0--0-63.32%1.25M--0--0--084.96%1.25M
-Change in prepaid assets -25.64%-21.69M-40.50%-10.67M-1,297.78%-10.08M11.88%-7.36M1,189.15%6.43M-250.12%-17.26M-67.48%-7.6M17.13%-721K-635.95%-8.35M-136.62%-590K
-Change in payables and accrued expense 684.81%121.8M-7.47%44.1M765.33%64.84M84.99%19.58M86.62%-6.72M-67.07%15.52M164.58%47.66M-8.14%7.49M-55.47%10.59M-1,692.26%-50.22M
-Change in other current assets -862.56%-12.87M-106.18%-154K18.55%3.79M-318.54%-17.27M512.00%765K94.02%1.69M-73.38%2.49M136.86%3.2M-4,789.77%-4.13M38.89%125K
-Change in other current liabilities -1,172.73%-420K-557.33%-1.03M-669.73%-2.11M126.36%750K-11.28%1.97M97.60%-33K132.19%225K14.91%370K-90.05%-2.85M344.29%2.22M
-Change in other working capital --------------------90.89%-762K----------------
Cash from discontinued investing activities
Operating cash flow -61.05%-897.74M-98.31%-274.24M-58.96%-207.31M-73.02%-221.76M-21.10%-194.44M-59.01%-557.44M-14.70%-138.29M-29.77%-130.42M-90.95%-128.17M-157.34%-160.56M
Investing cash flow
Cash flow from continuing investing activities 121.29%118.06M119.06%74.88M215.74%24.85M-68.25%34.28M93.57%-15.95M-61.82%-554.39M-3.29%-392.9M-127.75%-21.47M347.90%107.94M-6,305.36%-247.97M
Net PPE purchase and sale -55.12%-15.99M-57.53%-1.93M4.86%-3.35M-210.55%-7.45M-3.13%-3.27M-33.37%-10.31M47.26%-1.22M-38.86%-3.52M-114.39%-2.4M-80.15%-3.17M
Net investment purchase and sale 124.64%134.05M119.61%76.81M257.10%28.2M-62.19%41.73M94.82%-12.68M-62.48%-544.09M-3.60%-391.68M-122.47%-17.95M360.09%110.34M-4,354.41%-244.8M
Cash from discontinued investing activities
Investing cash flow 121.29%118.06M119.06%74.88M215.74%24.85M-68.25%34.28M93.57%-15.95M-61.82%-554.39M-3.29%-392.9M-127.75%-21.47M347.90%107.94M-6,305.36%-247.97M
Financing cash flow
Cash flow from continuing financing activities -35.22%621.52M-58.15%365.66M-102.06%-1.59M3,319.28%256.58M7.90%874K-21.95%959.41M4.10%873.81M7,545.30%77.29M-88.39%7.5M-99.75%810K
Net common stock issuance -58.89%347.92M-54.94%347.92M------------119.40%846.35M--772.06M--74.29M--0--0
Proceeds from stock option exercised by employees 142.41%273.39M157.99%261.77M38.22%4.15M-12.30%6.58M10.12%892K1,600.30%112.78M3,885.31%101.47M196.83%3M191.19%7.5M62.32%810K
Net other financing activities -22.54%220K---244.02M---5.74M--250M---18K-99.97%284K----------------
Cash from discontinued financing activities
Financing cash flow -35.22%621.52M-58.15%365.66M-102.06%-1.59M3,319.28%256.58M7.90%874K-21.95%959.41M4.10%873.81M7,545.30%77.29M-88.39%7.5M-99.75%810K
Net cash flow
Beginning cash position -21.80%546.76M8.89%222.3M45.78%406.35M15.71%337.25M-21.80%546.76M328.55%699.18M-43.42%204.15M-27.21%278.74M-32.05%291.46M328.55%699.18M
Current changes in cash -3.77%-158.16M-51.46%166.3M-146.74%-184.05M643.30%69.1M48.61%-209.51M-128.43%-152.42M1.25%342.61M-237.01%-74.59M72.37%-12.72M-253.39%-407.72M
End cash Position -28.93%388.6M-28.93%388.6M8.89%222.3M45.78%406.35M15.71%337.25M-21.80%546.76M-21.80%546.76M-43.42%204.15M-27.21%278.74M-32.05%291.46M
Free cash flow -60.94%-913.73M-97.95%-276.16M-57.28%-210.66M-75.55%-229.21M-20.75%-197.7M-58.45%-567.74M-13.54%-139.51M-30.00%-133.94M-91.33%-130.57M-155.23%-163.73M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri Show More